Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,977 GBX | -0.30% | -0.55% | +10.84% |
03:10pm | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.73% | 5.58B | |
+31.87% | 694B | |
+29.39% | 593B | |
-1.61% | 371B | |
+19.75% | 331B | |
+6.61% | 290B | |
+14.23% | 239B | |
-2.86% | 209B | |
+10.03% | 209B | |
+8.07% | 169B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC - Shareholder/Analyst Call